Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,275 | 143 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,001 | 74 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $195.58 | 11 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $167.43 | 9 | $0 (2024) |
| Alkermes, Inc. | $135.70 | 6 | $0 (2024) |
| Novo Nordisk Inc | $121.89 | 6 | $0 (2022) |
| Lundbeck LLC | $107.13 | 6 | $0 (2024) |
| Axsome Therapeutics, Inc. | $69.63 | 3 | $0 (2024) |
| Indivior Inc. | $67.23 | 4 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $59.51 | 3 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $58.03 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,257 | 83 | ABBVIE INC. ($483.32) |
| 2023 | $571.75 | 35 | ABBVIE INC. ($393.48) |
| 2022 | $237.59 | 13 | ABBVIE INC. ($95.10) |
| 2021 | $208.70 | 12 | Novo Nordisk Inc ($85.52) |
All Payment Transactions
143 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.97 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $1.25 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.92 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/07/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.47 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/05/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Neuroscience | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: OUD | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.52 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.80 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.15 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Neuroscience | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 195 | 238 | $30,726 | $13,795 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 79 | $12,721 | $6,208 | 48.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 45 | 45 | $6,179 | $2,863 | 46.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 43 | $5,674 | $2,368 | 41.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $4,254 | $2,027 | 47.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 14 | 15 | $1,170 | $158.66 | 13.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 13 | $177.15 | $100.81 | 56.9% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 22 | 22 | $550.10 | $68.50 | 12.5% |
About Ashley Swartz, NP-C
Ashley Swartz, NP-C is a Psychiatric/Mental Health healthcare provider based in Bedford, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/21/2019. The National Provider Identifier (NPI) number assigned to this provider is 1528601739.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashley Swartz, NP-C has received a total of $2,275 in payments from pharmaceutical and medical device companies, with $1,257 received in 2024. These payments were reported across 143 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,275).
As a Medicare-enrolled provider, Swartz has provided services to 195 Medicare beneficiaries, totaling 238 services with total Medicare billing of $13,795. Data is available for 1 year (2023–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Primary Care
- Location Bedford, PA
- Active Since 10/21/2019
- Last Updated 05/23/2023
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1528601739
Products in Payments
- VRAYLAR (Drug) $855.68
- CAPLYTA (Drug) $230.60
- MAVYRET (Drug) $145.13
- ARISTADA (Drug) $135.70
- INVEGA SUSTENNA (Drug) $133.42
- REXULTI (Drug) $121.40
- Auvelity (Drug) $69.63
- SUBLOCADE (Drug) $67.23
- Ozempic (Drug) $61.59
- INGREZZA (Drug) $59.51
- Qelbree (Drug) $58.03
- RYBELSUS (Drug) $41.00
- GARDASIL 9 (Biological) $35.72
- INVEGA TRINZA (Drug) $34.01
- Otezla (Drug) $20.59
- ABILIFY MAINTENA (Drug) $20.54
- Rybelsus (Drug) $19.30
- Fluad Quadrivalent (Biological) $18.67
- Aimovig (Biological) $17.71
- MOUNJARO (Drug) $17.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Bedford
Mrs. Christine Wysong, Rnpmhnp, RNPMHNP
Psychiatric/Mental Health — Payments: $9,472
Lisa Williams, Rn Aprn, RN APRN
Psychiatric/Mental Health — Payments: $5,925
Carrie Long, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $4,103
Mrs. Scheena Williams, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $3,899
Ms. Jennifer Tawa, Aprn, APRN
Psychiatric/Mental Health — Payments: $1,748
Pooja Cheema, Aprn, Pmhnp-Bc, APRN, PMHNP-BC
Psychiatric/Mental Health — Payments: $1,679